• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RGT 0.00% 31.0¢

ARGENT BIOPHARMA LIMITED - Announcements

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

Announcements


RGT Annual Report for the year ended 30 June 202001/10/20 download Created with Sketch. 1.36MB
RGT UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTSPRICE SENSITIVE28/09/20 download Created with Sketch. 206.98KB
RGT MXC WELCOMES NEW FCA GUIDANCE FOR CANNABIS SECTOR IN THE UKPRICE SENSITIVE21/09/20 download Created with Sketch. 174.66KB
RGT Issue of Securities - Appendix 2A15/09/20 download Created with Sketch. 326.36KB
RGT MXC WELL POSITIONED FOR TGA DOWN-SCHEDULE OF CBD PRODUCTSPRICE SENSITIVE14/09/20 download Created with Sketch. 188.23KB
RGT ProspectusPRICE SENSITIVE10/09/20 download Created with Sketch. 377.54KB
RGT Proposed issue of Securities - MXC10/09/20 download Created with Sketch. 30.69KB
RGT $15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETSPRICE SENSITIVE10/09/20 download Created with Sketch. 192.91KB
RGT Trading HaltPRICE SENSITIVE08/09/20 download Created with Sketch. 524.78KB
RGT Initial Director's Interest Notice - Appx 3X - Evan Hayes04/09/20 download Created with Sketch. 168.5KB
RGT BIOPHARMA APPOINTMENTS STRENGTHEN BOARD AND LEADERSHIP TEAM01/09/20 download Created with Sketch. 206.5KB
RGT Appendix 4E and Preliminary Unaudited Financial ReportPRICE SENSITIVE31/08/20 download Created with Sketch. 324.15KB
RGT JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIAPRICE SENSITIVE25/08/20 download Created with Sketch. 203.89KB
RGT COVID-19 Interim Trial Results Meet All Primary ObjectivesPRICE SENSITIVE20/08/20 download Created with Sketch. 448.05KB
RGT Trading HaltPRICE SENSITIVE19/08/20 download Created with Sketch. 171.85KB
RGT UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINESPRICE SENSITIVE14/08/20 download Created with Sketch. 238.84KB
RGT Change of Director's Interest Notice - Appendix 3Y x 213/08/20 download Created with Sketch. 391.04KB
RGT ProspectusPRICE SENSITIVE12/08/20 download Created with Sketch. 384.28KB
RGT Issue of Securities12/08/20 download Created with Sketch. 209.55KB
RGT Issue of Securities - Appendix 2A12/08/20 download Created with Sketch. 370.67KB
RGT Proposed issue of Securities - MXC12/08/20 download Created with Sketch. 33.26KB
RGT STUDY CONFIRMS EFFECTIVENESS OF ARTEMIC ON HUMAN IMMUNE CELLPRICE SENSITIVE07/08/20 download Created with Sketch. 380.7KB
RGT Trading haltPRICE SENSITIVE05/08/20 download Created with Sketch. 723.62KB
RGT Pause in tradingPRICE SENSITIVE05/08/20 download Created with Sketch. 116.59KB
RGT Appendix 2A - Exercise of MXCOE Options31/07/20 download Created with Sketch. 167.85KB
RGT June Quarterly Activity and Cashflow ReportPRICE SENSITIVE31/07/20 download Created with Sketch. 466.98KB
RGT Reinstatement to Official QuotationPRICE SENSITIVE27/07/20 download Created with Sketch. 71.21KB
RGT Results from ArtemiC Safety and Toxicity Pre-clinical StudyPRICE SENSITIVE27/07/20 download Created with Sketch. 188.12KB
RGT Suspension from Official QuotationPRICE SENSITIVE24/07/20 download Created with Sketch. 364.26KB
RGT Trading HaltPRICE SENSITIVE22/07/20 download Created with Sketch. 531.71KB
RGT Pause in TradingPRICE SENSITIVE22/07/20 download Created with Sketch. 115.35KB
RGT Proposed issue of Securities - MXC20/07/20 download Created with Sketch. 25.13KB
RGT MGC Pharma to acquire 100% of Medicinal Cannabis ClinicPRICE SENSITIVE20/07/20 download Created with Sketch. 190.65KB
RGT Change of Director's Interest Notice - Appendix 3Y x 215/07/20 download Created with Sketch. 99.75KB
RGT MXC Cannabis Research Permit Granted for RMIT ProgramsPRICE SENSITIVE14/07/20 download Created with Sketch. 173.39KB
RGT Appendix 2A10/07/20 download Created with Sketch. 415.39KB
RGT MGC Pharma awarded Import Licence by Office of Drug ControlPRICE SENSITIVE08/07/20 download Created with Sketch. 173.6KB
RGT Results of General Meeting02/07/20 download Created with Sketch. 617.69KB
RGT COVID-19 Clinical Trial Site Expansion into IndiaPRICE SENSITIVE02/07/20 download Created with Sketch. 202.65KB
RGT MGC Pharma GM Webinar26/06/20 download Created with Sketch. 162.07KB
RGT INVESTOR PRESENTATIONPRICE SENSITIVE24/06/20 download Created with Sketch. 1.6MB
RGT MXC Awarded 3-year EU GMP Manufacturing LicencePRICE SENSITIVE23/06/20 download Created with Sketch. 216.83KB
RGT Unmarketable Parcel Share Sale Facility22/06/20 download Created with Sketch. 643.26KB
RGT Sale of MGC Nutra to US CBD and Hemp Wellness CompanyPRICE SENSITIVE18/06/20 download Created with Sketch. 186.84KB
RGT Binding Term Sheet for distribution of CannEpil in IsraelPRICE SENSITIVE15/06/20 download Created with Sketch. 186.78KB
RGT 3,250 Prescriptions Milestone SurpassedPRICE SENSITIVE02/06/20 download Created with Sketch. 240.84KB
RGT Letter to Shareholders - Upcoming General Meeting29/05/20 download Created with Sketch. 298.9KB
RGT Notice of General Meeting/Proxy Form29/05/20 download Created with Sketch. 502.3KB
RGT Ethics Committee Approval for CannEpil Phase IIb TrialPRICE SENSITIVE26/05/20 download Created with Sketch. 223.1KB
RGT Reinstatement to Official QuotationPRICE SENSITIVE13/05/20 download Created with Sketch. 400.82KB
RGT Binding Term Sheet Signed for Distribution of ArtemiCPRICE SENSITIVE13/05/20 download Created with Sketch. 188KB
RGT Extension of Voluntary Suspension12/05/20 download Created with Sketch. 145.04KB
RGT Issue of Options - Appendix 2A11/05/20 download Created with Sketch. 287.47KB
RGT Voluntary SuspensionPRICE SENSITIVE11/05/20 download Created with Sketch. 543.89KB
RGT Trading HaltPRICE SENSITIVE07/05/20 download Created with Sketch. 182.93KB
RGT Pause in TradingPRICE SENSITIVE07/05/20 download Created with Sketch. 115.87KB
RGT Phase II Clinical Trial on COVID-19 Patients CommencedPRICE SENSITIVE05/05/20 download Created with Sketch. 174.82KB
RGT Completion of $3.5m Placement - Appendix 2A04/05/20 download Created with Sketch. 287.27KB
RGT Proposed issue of Securities - MXC04/05/20 download Created with Sketch. 24.56KB
RGT ProspectusPRICE SENSITIVE04/05/20 download Created with Sketch. 390.01KB
RGT March Quarterly Activity and Cashflow ReportPRICE SENSITIVE29/04/20 download Created with Sketch. 896.88KB
RGT Second Ethics Committee Approval for Phase II COVID-19 TrialPRICE SENSITIVE28/04/20 download Created with Sketch. 208.85KB
RGT Proposed issue of Securities - MXC28/04/20 download Created with Sketch. 24.56KB
RGT Proposed issue of Securities - MXC28/04/20 download Created with Sketch. 28.58KB
RGT MGC Pharma Secures Commitments for $3.5m PlacementPRICE SENSITIVE28/04/20 download Created with Sketch. 171.53KB
RGT Trading HaltPRICE SENSITIVE24/04/20 download Created with Sketch. 519.42KB
RGT Successful Research Results for MGC on GlioblastomaPRICE SENSITIVE22/04/20 download Created with Sketch. 521.65KB
RGT Phase II Clinical Trial on Patients Diagnosed with COVID-19PRICE SENSITIVE17/04/20 download Created with Sketch. 337.13KB
RGT Pause In TradePRICE SENSITIVE17/04/20 download Created with Sketch. 116.11KB
RGT Reinstatement to Official QuotationPRICE SENSITIVE15/04/20 download Created with Sketch. 72.68KB
RGT MGC Pharma Signs Agreement Targeting Anti-Viral TreatmentsPRICE SENSITIVE15/04/20 download Created with Sketch. 212.11KB
RGT MGC Pharma Listing Rule 10.19 Correction15/04/20 download Created with Sketch. 161.42KB
RGT Suspension from Official QuotationPRICE SENSITIVE08/04/20 download Created with Sketch. 72.74KB
RGT MGC Pharma COVID-19 Business and Operations UpdatePRICE SENSITIVE06/04/20 download Created with Sketch. 179.46KB
RGT Voluntary Suspension Extension03/04/20 download Created with Sketch. 141.32KB
RGT Voluntary Suspension Extension02/04/20 download Created with Sketch. 141.29KB
RGT Voluntary Suspension Extension31/03/20 download Created with Sketch. 171.2KB
RGT Voluntary Suspension Extension27/03/20 download Created with Sketch. 141.27KB
RGT Voluntary Suspension Extension26/03/20 download Created with Sketch. 173.26KB
RGT Voluntary Suspension Extension25/03/20 download Created with Sketch. 141.08KB
RGT Voluntary Suspension Extension24/03/20 download Created with Sketch. 141.16KB
RGT Change of Director's Interest Notice - Appendix 3Y x 223/03/20 download Created with Sketch. 251KB
RGT Suspension from Official QuotationPRICE SENSITIVE23/03/20 download Created with Sketch. 208.57KB
RGT Trading HaltPRICE SENSITIVE19/03/20 download Created with Sketch. 335.7KB
RGT SPP - Appendix 2A17/03/20 download Created with Sketch. 167.61KB
RGT Operational Update and Share Purchase Plan Completion16/03/20 download Created with Sketch. 208.5KB
RGT Patients Begin Treatment in Clinical Trial of CogniCannPRICE SENSITIVE09/03/20 download Created with Sketch. 182.93KB
RGT Extension of SPP Closing Date03/03/20 download Created with Sketch. 132.61KB
RGT Binding Amendment to Supply Agreement with ONIX BrazilPRICE SENSITIVE03/03/20 download Created with Sketch. 201.17KB
RGT Half Yearly Report and AccountsPRICE SENSITIVE28/02/20 download Created with Sketch. 660.78KB
RGT Trading HaltPRICE SENSITIVE28/02/20 download Created with Sketch. 337.81KB
RGT Notice Under Section 708A(5)(e) of the Corporations Act27/02/20 download Created with Sketch. 152.71KB
RGT Commercial Supply Deal Signed for First Products into PolandPRICE SENSITIVE26/02/20 download Created with Sketch. 213.96KB
RGT Completion of $1m Placement - Appendix 2A25/02/20 download Created with Sketch. 323.88KB
RGT 85% Increase in Order Volume of New Prescription ProductsPRICE SENSITIVE21/02/20 download Created with Sketch. 207.66KB
RGT SPP Offer Document and Application Forms Despatched20/02/20 download Created with Sketch. 178.57KB
RGT Security Purchase Plan- Offer DocumentPRICE SENSITIVE17/02/20 download Created with Sketch. 235.35KB
RGT Notice Under Section 708A(5)(e) of the Corporations Act17/02/20 download Created with Sketch. 155.37KB
RGT Proposed issue of Securities - MXC17/02/20 download Created with Sketch. 38.8KB
RGT MGC Pharma announces $1m Strategic Placement and $3m SPPPRICE SENSITIVE17/02/20 download Created with Sketch. 198.96KB
RGT Annual Report for the year ended 30 June 2020
01/10/20 download Created with Sketch. 1.36MB
RGT UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
28/09/20PRICE SENSITIVE download Created with Sketch. 206.98KB
RGT MXC WELCOMES NEW FCA GUIDANCE FOR CANNABIS SECTOR IN THE UK
21/09/20PRICE SENSITIVE download Created with Sketch. 174.66KB
RGT Issue of Securities - Appendix 2A
15/09/20 download Created with Sketch. 326.36KB
RGT MXC WELL POSITIONED FOR TGA DOWN-SCHEDULE OF CBD PRODUCTS
14/09/20PRICE SENSITIVE download Created with Sketch. 188.23KB
RGT Prospectus
10/09/20PRICE SENSITIVE download Created with Sketch. 377.54KB
RGT Proposed issue of Securities - MXC
10/09/20 download Created with Sketch. 30.69KB
RGT $15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETS
10/09/20PRICE SENSITIVE download Created with Sketch. 192.91KB
RGT Trading Halt
08/09/20PRICE SENSITIVE download Created with Sketch. 524.78KB
RGT Initial Director's Interest Notice - Appx 3X - Evan Hayes
04/09/20 download Created with Sketch. 168.5KB
RGT BIOPHARMA APPOINTMENTS STRENGTHEN BOARD AND LEADERSHIP TEAM
01/09/20 download Created with Sketch. 206.5KB
RGT Appendix 4E and Preliminary Unaudited Financial Report
31/08/20PRICE SENSITIVE download Created with Sketch. 324.15KB
RGT JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
25/08/20PRICE SENSITIVE download Created with Sketch. 203.89KB
RGT COVID-19 Interim Trial Results Meet All Primary Objectives
20/08/20PRICE SENSITIVE download Created with Sketch. 448.05KB
RGT Trading Halt
19/08/20PRICE SENSITIVE download Created with Sketch. 171.85KB
RGT UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINES
14/08/20PRICE SENSITIVE download Created with Sketch. 238.84KB
RGT Change of Director's Interest Notice - Appendix 3Y x 2
13/08/20 download Created with Sketch. 391.04KB
RGT Prospectus
12/08/20PRICE SENSITIVE download Created with Sketch. 384.28KB
RGT Issue of Securities
12/08/20 download Created with Sketch. 209.55KB
RGT Issue of Securities - Appendix 2A
12/08/20 download Created with Sketch. 370.67KB
RGT Proposed issue of Securities - MXC
12/08/20 download Created with Sketch. 33.26KB
RGT STUDY CONFIRMS EFFECTIVENESS OF ARTEMIC ON HUMAN IMMUNE CELL
07/08/20PRICE SENSITIVE download Created with Sketch. 380.7KB
RGT Trading halt
05/08/20PRICE SENSITIVE download Created with Sketch. 723.62KB
RGT Pause in trading
05/08/20PRICE SENSITIVE download Created with Sketch. 116.59KB
RGT Appendix 2A - Exercise of MXCOE Options
31/07/20 download Created with Sketch. 167.85KB
RGT June Quarterly Activity and Cashflow Report
31/07/20PRICE SENSITIVE download Created with Sketch. 466.98KB
RGT Reinstatement to Official Quotation
27/07/20PRICE SENSITIVE download Created with Sketch. 71.21KB
RGT Results from ArtemiC Safety and Toxicity Pre-clinical Study
27/07/20PRICE SENSITIVE download Created with Sketch. 188.12KB
RGT Suspension from Official Quotation
24/07/20PRICE SENSITIVE download Created with Sketch. 364.26KB
RGT Trading Halt
22/07/20PRICE SENSITIVE download Created with Sketch. 531.71KB
RGT Pause in Trading
22/07/20PRICE SENSITIVE download Created with Sketch. 115.35KB
RGT Proposed issue of Securities - MXC
20/07/20 download Created with Sketch. 25.13KB
RGT MGC Pharma to acquire 100% of Medicinal Cannabis Clinic
20/07/20PRICE SENSITIVE download Created with Sketch. 190.65KB
RGT Change of Director's Interest Notice - Appendix 3Y x 2
15/07/20 download Created with Sketch. 99.75KB
RGT MXC Cannabis Research Permit Granted for RMIT Programs
14/07/20PRICE SENSITIVE download Created with Sketch. 173.39KB
RGT Appendix 2A
10/07/20 download Created with Sketch. 415.39KB
RGT MGC Pharma awarded Import Licence by Office of Drug Control
08/07/20PRICE SENSITIVE download Created with Sketch. 173.6KB
RGT Results of General Meeting
02/07/20 download Created with Sketch. 617.69KB
RGT COVID-19 Clinical Trial Site Expansion into India
02/07/20PRICE SENSITIVE download Created with Sketch. 202.65KB
RGT MGC Pharma GM Webinar
26/06/20 download Created with Sketch. 162.07KB
RGT INVESTOR PRESENTATION
24/06/20PRICE SENSITIVE download Created with Sketch. 1.6MB
RGT MXC Awarded 3-year EU GMP Manufacturing Licence
23/06/20PRICE SENSITIVE download Created with Sketch. 216.83KB
RGT Unmarketable Parcel Share Sale Facility
22/06/20 download Created with Sketch. 643.26KB
RGT Sale of MGC Nutra to US CBD and Hemp Wellness Company
18/06/20PRICE SENSITIVE download Created with Sketch. 186.84KB
RGT Binding Term Sheet for distribution of CannEpil in Israel
15/06/20PRICE SENSITIVE download Created with Sketch. 186.78KB
RGT 3,250 Prescriptions Milestone Surpassed
02/06/20PRICE SENSITIVE download Created with Sketch. 240.84KB
RGT Letter to Shareholders - Upcoming General Meeting
29/05/20 download Created with Sketch. 298.9KB
RGT Notice of General Meeting/Proxy Form
29/05/20 download Created with Sketch. 502.3KB
RGT Ethics Committee Approval for CannEpil Phase IIb Trial
26/05/20PRICE SENSITIVE download Created with Sketch. 223.1KB
RGT Reinstatement to Official Quotation
13/05/20PRICE SENSITIVE download Created with Sketch. 400.82KB
RGT Binding Term Sheet Signed for Distribution of ArtemiC
13/05/20PRICE SENSITIVE download Created with Sketch. 188KB
RGT Extension of Voluntary Suspension
12/05/20 download Created with Sketch. 145.04KB
RGT Issue of Options - Appendix 2A
11/05/20 download Created with Sketch. 287.47KB
RGT Voluntary Suspension
11/05/20PRICE SENSITIVE download Created with Sketch. 543.89KB
RGT Trading Halt
07/05/20PRICE SENSITIVE download Created with Sketch. 182.93KB
RGT Pause in Trading
07/05/20PRICE SENSITIVE download Created with Sketch. 115.87KB
RGT Phase II Clinical Trial on COVID-19 Patients Commenced
05/05/20PRICE SENSITIVE download Created with Sketch. 174.82KB
RGT Completion of $3.5m Placement - Appendix 2A
04/05/20 download Created with Sketch. 287.27KB
RGT Proposed issue of Securities - MXC
04/05/20 download Created with Sketch. 24.56KB
RGT Prospectus
04/05/20PRICE SENSITIVE download Created with Sketch. 390.01KB
RGT March Quarterly Activity and Cashflow Report
29/04/20PRICE SENSITIVE download Created with Sketch. 896.88KB
RGT Second Ethics Committee Approval for Phase II COVID-19 Trial
28/04/20PRICE SENSITIVE download Created with Sketch. 208.85KB
RGT Proposed issue of Securities - MXC
28/04/20 download Created with Sketch. 24.56KB
RGT Proposed issue of Securities - MXC
28/04/20 download Created with Sketch. 28.58KB
RGT MGC Pharma Secures Commitments for $3.5m Placement
28/04/20PRICE SENSITIVE download Created with Sketch. 171.53KB
RGT Trading Halt
24/04/20PRICE SENSITIVE download Created with Sketch. 519.42KB
RGT Successful Research Results for MGC on Glioblastoma
22/04/20PRICE SENSITIVE download Created with Sketch. 521.65KB
RGT Phase II Clinical Trial on Patients Diagnosed with COVID-19
17/04/20PRICE SENSITIVE download Created with Sketch. 337.13KB
RGT Pause In Trade
17/04/20PRICE SENSITIVE download Created with Sketch. 116.11KB
RGT Reinstatement to Official Quotation
15/04/20PRICE SENSITIVE download Created with Sketch. 72.68KB
RGT MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
15/04/20PRICE SENSITIVE download Created with Sketch. 212.11KB
RGT MGC Pharma Listing Rule 10.19 Correction
15/04/20 download Created with Sketch. 161.42KB
RGT Suspension from Official Quotation
08/04/20PRICE SENSITIVE download Created with Sketch. 72.74KB
RGT MGC Pharma COVID-19 Business and Operations Update
06/04/20PRICE SENSITIVE download Created with Sketch. 179.46KB
RGT Voluntary Suspension Extension
03/04/20 download Created with Sketch. 141.32KB
RGT Voluntary Suspension Extension
02/04/20 download Created with Sketch. 141.29KB
RGT Voluntary Suspension Extension
31/03/20 download Created with Sketch. 171.2KB
RGT Voluntary Suspension Extension
27/03/20 download Created with Sketch. 141.27KB
RGT Voluntary Suspension Extension
26/03/20 download Created with Sketch. 173.26KB
RGT Voluntary Suspension Extension
25/03/20 download Created with Sketch. 141.08KB
RGT Voluntary Suspension Extension
24/03/20 download Created with Sketch. 141.16KB
RGT Change of Director's Interest Notice - Appendix 3Y x 2
23/03/20 download Created with Sketch. 251KB
RGT Suspension from Official Quotation
23/03/20PRICE SENSITIVE download Created with Sketch. 208.57KB
RGT Trading Halt
19/03/20PRICE SENSITIVE download Created with Sketch. 335.7KB
RGT SPP - Appendix 2A
17/03/20 download Created with Sketch. 167.61KB
RGT Operational Update and Share Purchase Plan Completion
16/03/20 download Created with Sketch. 208.5KB
RGT Patients Begin Treatment in Clinical Trial of CogniCann
09/03/20PRICE SENSITIVE download Created with Sketch. 182.93KB
RGT Extension of SPP Closing Date
03/03/20 download Created with Sketch. 132.61KB
RGT Binding Amendment to Supply Agreement with ONIX Brazil
03/03/20PRICE SENSITIVE download Created with Sketch. 201.17KB
RGT Half Yearly Report and Accounts
28/02/20PRICE SENSITIVE download Created with Sketch. 660.78KB
RGT Trading Halt
28/02/20PRICE SENSITIVE download Created with Sketch. 337.81KB
RGT Notice Under Section 708A(5)(e) of the Corporations Act
27/02/20 download Created with Sketch. 152.71KB
RGT Commercial Supply Deal Signed for First Products into Poland
26/02/20PRICE SENSITIVE download Created with Sketch. 213.96KB
RGT Completion of $1m Placement - Appendix 2A
25/02/20 download Created with Sketch. 323.88KB
RGT 85% Increase in Order Volume of New Prescription Products
21/02/20PRICE SENSITIVE download Created with Sketch. 207.66KB
RGT SPP Offer Document and Application Forms Despatched
20/02/20 download Created with Sketch. 178.57KB
RGT Security Purchase Plan- Offer Document
17/02/20PRICE SENSITIVE download Created with Sketch. 235.35KB
RGT Notice Under Section 708A(5)(e) of the Corporations Act
17/02/20 download Created with Sketch. 155.37KB
RGT Proposed issue of Securities - MXC
17/02/20 download Created with Sketch. 38.8KB
RGT MGC Pharma announces $1m Strategic Placement and $3m SPP
17/02/20PRICE SENSITIVE download Created with Sketch. 198.96KB
(20min delay)
Last
31.0¢
Change
0.000(0.00%)
Mkt cap ! $14.03M
Open High Low Value Volume
31.0¢ 31.0¢ 31.0¢ $1.272K 4.102K

Buyers (Bids)

No. Vol. Price($)
3 2947 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 2876 1
View Market Depth
Last trade - 15.56pm 19/06/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.